Qualis Logo.png
Qualis Innovations Inc. Announces the Appointment of Skip Thurman as Sr. Vice President, Corporate and IR Communications of mPathix Health Inc.
03 août 2021 16h44 HE | Qualis Innovations, Inc.
Chadds Ford, PA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- mPathix Health Inc., a wholly owned subsidiary of Qualis Innovations Inc., (OTC: QLIS), a pain solutions company focused on developing and...
Logo.jpg
Results of Celsion’s OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research
29 juil. 2021 10h00 HE | Celsion CORP
Data show dose-dependent suppression of immune-suppressive agents GEN-1 stimulates the immune system through the production of CD4 and CD8 cells Chemotherapy Response...
Healixa Inc. to Establish Nationally Recognized Medical Advisory Committee
15 avr. 2021 14h16 HE | Emerald Organic Products Inc.
Holbrook, New York, April 15, 2021 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the “Company”, "EMOR", “Healixa”), a people-first digital organization that...
Coronavirus Relief & Omnibus Agreement Authorizes PAs to Receive Direct Payment Under Medicare
28 déc. 2020 12h51 HE | American Academy of PAs
Alexandria, VA, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AAPA commends Congress for passing legislation authorizing PAs to receive direct payment under Medicare as part of the Coronavirus Relief &...
Strata Report Reveals COVID-19 Impact on U.S. Healthcare Delivery
23 sept. 2020 08h50 HE | Strata Decision Technology, L.L.C.
CHICAGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- A comprehensive six-month study of patient and procedure volume at 275 hospitals by Strata Decision Technology (Strata) revealed the significant financial...
Free National Financial Resource Directory Connects People to the Resources They Need
14 sept. 2020 13h08 HE | Patient Advocate Foundation
Hampton, VA, Sept. 14, 2020 (GLOBE NEWSWIRE) -- With families nationwide in search of more resources to support themselves through difficult times, the Patient Advocate Foundation relaunched the...
provectus_logo.jpg
Provectus Announces Presentation of Updated Data from Metastatic Uveal Melanoma Cohort of Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
01 juin 2020 09h00 HE | Provectus Biopharmaceuticals Inc.
Treatment refractory, immunologically cold, hepatic tumor type37% reduction and 83% stabilization of treated disease (2D-EASL)Overall survival of 11 months for checkpoint inhibition-naïve patients;...
TULogo-blue-WCAG-rgb-300x80.jpg
Overall Hospital Visit Recovery Sluggish Despite Positive Upward Trends in Outpatient Visits
01 juin 2020 08h00 HE | TransUnion
CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Ongoing research from TransUnion Healthcare (NYSE: TRU) indicates overall hospital visit volumes continue to slowly recover, though hospital visit volumes...
provectus_logo.jpg
Provectus Announces Publication of Updated Data from Metastatic Neuroendocrine Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
01 juin 2020 07h00 HE | Provectus Biopharmaceuticals Inc.
Treatment refractory, immunologically cold, hepatic tumor type50% reduction of treated disease; 83% stabilization of overall patient disease (RECIST)Median progression-free survival not reached (by CT...
Marius_logo_CMYK.jpg
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
21 mai 2020 06h30 HE | Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...